HCA Healthcare, Inc. (HCA)

HCA Healthcare Stock Forecast

Stock Price Forecast

According to 14 professional analysts, the 12-month price target for HCA Healthcare stock ranges from a low of $336 to a high of $440. The average analyst price target of $387 forecasts a 0.30% increase in the stock price over the next year.

Price Target: $387.00 (+0.30%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$336	$387	$385	$440
Change	-12.92%	+0.30%	-0.22%	+14.03%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	4
Buy	7	7	7	6	6	6
Hold	4	4	4	6	7	6
Sell	1	1	1	1	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Mok Barclays	Barclays	Buy Maintains $366 → $416	Buy	Maintains	$366 → $416	+7.81%	Jun 2, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Sell → Hold Upgrades $320 → $385	Sell → Hold	Upgrades	$320 → $385	-0.22%	May 29, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $384 → $376	Buy	Maintains	$384 → $376	-2.56%	Apr 28, 2025
Michael Ha Baird	Baird	Buy → Hold Downgrades $396 → $336	Buy → Hold	Downgrades	$396 → $336	-12.92%	Apr 15, 2025
Jason Cassorla Guggenheim	Guggenheim	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Apr 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

75.48B

Increased by 6.91%

from 70.60B

Revenue Next Year

79.35B

Increased by 5.13%

from 75.48B

EPS This Year

25.62

Increased by 16.45%

from 22.00

EPS Next Year

28.45

Increased by 11.03%

from 25.62

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	51.53B	58.75B	60.23B	64.97B	70.60B	75.48B	79.35B	83.50B
Revenue Growth	0.38%	14.01%	2.52%	7.86%	8.67%	6.91%	5.13%	5.23%
EPS	10.93	21.16	19.15	18.97	22.00	25.62	28.45	32.25
EPS Growth	8.54%	93.60%	-9.50%	-0.94%	15.97%	16.45%	11.03%	13.38%
Forward PE	-	-	-	-	-	15.06	13.56	11.96
No. Analysts	-	-	-	-	-	26	25	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	79.6B	84.9B	90.4B
Avg	75.5B	79.4B	83.5B
Low	72.2B	75.7B	79.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.7%	12.5%	13.9%
Avg	6.9%	5.1%	5.2%
Low	2.2%	0.2%	-0.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	27.17	31.49	35.77
Avg	25.62	28.45	32.25
Low	24.32	26.50	30.44

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	23.5%	22.9%	25.8%
Avg	16.4%	11.0%	13.4%
Low	10.6%	3.4%	7.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.